Company intelligence / Profile preview
Orion Corporation
Espoo, Uusimaa, Finlandorionpharma.com ↗
- Ownership
- Public · ORN
- Employees
- ~3880
- Development stage
- Other
01
Overview
Orion has a broad commercial product portfolio with several proprietary and generic medicines on the market. Its pipeline includes investigational candidates in neurology, oncology, and respiratory diseases. The company is expanding into biologics R&D and antibody therapeutics through recent partnerships.[2][5]
- Therapeutic areas
- PulmonologyCardiovascularNeurology
- Modalities
- Small moleculesInhaled drugs (Easyhaler® device portfolio)Antibody therapeutics (recent partnerships)
- Industry
- Biotech
02
Drug pipeline
41 assets40 more assets in the full pipeline.
03
Partnerships
Bayer AG – co-development of Nubeqa/darolutamide for prostate cancer [2][7]Abilita Therapeutics – antibody therapeutics partnership in oncology/pain management [2]Aitia – digital twins technology partnership for cancer research [2]
04
Financials
- Market cap
- $280.1M
- Total revenue
- $852.3M
- Enterprise value
- $430.9M
Beyond the preview
Go deeper on Orion Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Orion Corporation.